Johnson & Johnson

NYSE
JNJ
Stock
Yield per half year: +3.26%
Dividend yield: 3.09%
Sector: Healthcare

Johnson & Johnson

176.00176.00168.00168.00160.00160.00152.00152.00144.00144.00136.00136.00Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
24.53 52.65 -53.41% 22.42 +9.41%
P/S 3.88 4.03 -3.68%
P/BV 4.83 10.87 -55.59%
P/FCF 22.59 39.64 -43%
Ev/Ebitda 14.43 16.1 -10.41%
Ev/S 4.03 4.35 -7.5%
Ev/FCF 18.02 52.31 -65.55%
E/P 0.0314 0.2095 -85.01%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
27.9 19.07 46.26% 30.32 -7.99%
ROE 20.06 -83.32 -124.07%
ROA 8.09 6.38 26.86%
ROIC 19.19 15.06 27.42%
ROS 15.84 9.34 69.68%
ROCE 24.4 84.76 -71.21%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.48 1.01 46.71% 1.35 +9.85%
Nеt Debt/Ebitda 0.5056 1.4 -63.83%
Debt/Ratio 0.2034 0.2742 -25.81%
Debt/Equity 1.52 15.68 -90.31%
Debt/Net Income 2.6 6.8 -61.71%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
7.73/10
3.09 1.28 140.71% 2.96 +4.22%
Number of years of dividend growth 40 6.75 492.94%
DSI 1 0.7413 34.89%
Average dividend growth 5.43 -4.1 -232.39%
Average percentage for 5 years 2.96 1.33 122.55%
Average percentage for payments 46.33 44.08 5.09%
Difference from average difference in sector 1.81

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
7.56 12.47 -39.37%
Growth impulse Ebitda in 5 years 21.83 -86.3 -125.3%
Growth impulse Net Income in 5 years -4.38 -75.86 -94.23%
Growth impulse FCF in 5 years -1.72 -79.28 -97.83%
Growth impulse EPS in 5 years 6.06 4.34 39.63%
IP Score
6.06/10

Similar companies

AbbVie

Eli Lilly and Company

PFIZER

Zoetis

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription